We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Type Predisposes to Certain Viral Infections

By LabMedica International staff writers
Posted on 30 Apr 2012
Some strains of Rotavirus find their way into the cells of the gastrointestinal tract by recognizing antigens associated with the type A blood group. More...


Histo-blood group antigens are known to promote binding of Norovirus and Helicobacter pylori cells to intestinal cells, but this had never been demonstrated in Rotavirus, a major intestinal pathogen that is the leading cause of severe dehydration and diarrhea in infants around the world.

Scientists at Baylor College of Medicine (Houston, TX, USA) examined the structure of a key part of a strain of the virus known as P[14] which provides a clue to how the virus infects human cells. The scientists used various techniques including protein expression and purification, crystallization, glycan array screening, inhibition and infectivity assays, and hemagglutination assays.

In strains of Rotavirus that infect animals, the top of a spike on the virus attaches to the cell via a glycan, one of many sugars linked together to form complex branched-chain structures with a terminal molecule of sialic acid. The same did not appear to be true of virus strains that infect humans, and scientists believed the human Rotavirus strains were bound to glycans with an internal sialic acid molecule, but they did not know how this occurs.

The investigators determined the structure of the top of the virus spike domain, known as VP8*, and found that the type A glycan bound to the Rotavirus spike protein at the same place as the sialic acid would have in an animal Rotavirus. They used crystallography, to show subtle changes in the structure of the VP8* domain of the virus that allowed it to use the histo-blood group antigen A as a receptor. An antibody to the histo-blood group antigen A blocked infection by the virus into human intestinal cells in culture. The authors found humans infected with the P[14] strain had type A blood, but more studies are needed to confirm the connection.

B. V. Venkataram Prasad, PhD, the lead author and professor of biochemistry and molecular biology at Baylor College of Medicine, said, "We wondered how this genotype of Rotavirus recognized a cellular glycan. We did a glycan array analysis to see which glycans interacted with the top of the virus spike, called VP8*. No one expected this. Is there an emerging theme here with these intestinal pathogens? Do other viruses use these blood group antigens as a door to enter the cell? The question now is do different strains use other histo-blood group antigens in this way?" Further studies identified a second Rotavirus strain P[9] that uses the histo-blood group antigen as a receptor. The study was published online on April 15 2012 in the journal Nature.

Related Links:
Baylor College of Medicine



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.